Session – EAU17 London

Primary treatment of prostate cancer: Balancing benefits and side effects

Poster Session 81

Monday 27 March
15:45 - 17:15

Location:

Room Milan, North Hall (Level 1)
Chairs:

G.M. Ahlgren, Malmö (SE)
G. Giannarini, Udine (IT)
R.C.N. Van Den Bergh, Amsterdam (NL)
Aims and objectives of this session

The aim of this session is to discuss on oncological and functional outcomes on primary treatments for prostate cancer.
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.

1070

The BAUS radical prostatectomy audit 2014/2015 – an update on current practice and outcomes by centre and surgeon case volume

By: Khadhouri S.¹, Miller C.¹, McNeill A.², Hounsome L.³, Fowler S.⁴, McGrath J.¹

Institutes: ¹Royal Devon and Exeter Hospital, Dept. of Urology, Exeter, United Kingdom, ²Western General Hospital, Dept. of Urology, Edinburgh, United Kingdom, ³Public Health England, Dept. of Public Health, London, United Kingdom, ⁴BAUS, Dept. of Surgery, London, United Kingdom

1071

Efficacy of local treatment in prostate cancer patients with clinically pelvic lymph node-positive disease at initial diagnosis

By: Seisen T.¹, Vetterlein M.¹, Karabon P.¹, Jindal T.¹, Sood A.¹, Nocera L.¹, Nguyen P.², Choueiri T.³, Trinh Q-D.⁴, Menon M.¹, Abdollah F.¹

Institutes: ¹Henri Ford Hospital, Dept. of Urology, Detroit, United States of America, ²Brigham and Women Hospital, Dept. of Radiation Oncology, Boston, United States of America, ³Dana Farber Cancer Institute, Dept. of Genito-Urinary Medical Oncology, Boston, United States of America, ⁴Brigham and Women’s Hospital, Dept. of Urology, Boston, United States of America

1072

Oncological and functional outcomes of laparoscopic versus robot-assisted radical prostatectomy: Five years results of a prospective randomised controlled trial

By: Porpiglia F.¹, Fiori C.¹, Bertolo R.¹, Manfredi M.¹, Mele F.¹, Garrou D.¹, Cattaneo G.¹, De Luca S.¹, Passera R.², Scarpa R.M.¹

Institutes: ¹San Luigi Hospital, Dept. of Urology, Turin, Italy, ²San Giovanni Battista Hospital, Dept. of Nuclear Medicine, Turin, Italy

1073

Contemporary extended pelvic lymph node dissection for prostate cancer in the UK – an analysis of national practice

By: Calleja E., Fowler S., McGrath J., Sooriakumaran P., Aning J.

Institutes: BAUS Section of Oncology, British Association of Urological Surgeons, London, United Kingdom

1075

More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes after salvage radiotherapy for rising PSA after surgery: A long-term, multi-institutional analysis

By: Fossati N.¹, Karnes R.J.², Colicchia M.², Bossi A.³, Cozzarini C.⁴, Fiorino C.⁴, Noris Chiorda B.⁴, Gandaglia G.¹, Dell’Oglio P.¹, Wiegel T.⁵, Shariat S.⁶, Goldner G.⁷, Joniau S.⁸, Battaglia A.⁸, Haustermans K.⁹, De Meerleer G.⁹, Fonteyne V.¹⁰, Ost P.¹⁰, Van Poppel H.⁵, Montorsi F.¹, Briganti A.¹, Boorjian S.A.²

Institutes: ¹Vita-Salute University San Raffaele, Dept. of Urology, Milan, Italy, ²Mayo Clinic, Dept. of Urology, Rochester, United States of America, ³Gustave Roussy Institute, Dept. of Radiation Oncology, Villejuif, France, ⁴IRCCS Ospedale San Raffaele, Dept. of Radiotherapy, Milan, Italy, ⁵University Hospital Ulm, Dept. of Radiation Oncology, Ulm, Germany, ⁶Medical University of Vienna, Dept. of Urology, Vienna, Austria, ⁷Medical University of Vienna, Dept. of Radiation Oncology, Vienna, Austria, ⁸University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, ⁹University Hospitals Leuven, Dept. of Radiotherapy, Leuven, Belgium, ¹⁰Ghent University Hospital, Dept. of Radiotherapy, Ghent, Belgium

1074

Applicability of Briganti nomogram: Is it an absolute requirement before lymph node dissection in intermediate-risk prostate cancer? Assessment of the external applicability

By: Pradere B., Roumiguié M., Sanson S., Gas J., Patard P.M., Huyghe E., Rischmann P., Gamé X., Thoulouzan M., Doumerc N., Soulié M., Beauval J.B.

Institutes: CHU Toulouse, Dept. of Urology, Toulouse, France

1076

The CPC risk calculator app: A validated tool to predict recurrence after radical prostatectomy.

By: Røder M.A.¹, Berg K.D.¹, Loft M.D.², Gerds T.A.³, Ferrari M.², Thomsen F.B.¹, Gruschy L.¹, Kurbegovic S.¹, Rytgaard H.C.³, Kjær A.⁴, Brasso K.¹, Iversen P.¹, Brooks J.²

Institutes: ¹Rigshospitalet, Copenhagen Prostate Cancer Center, Dept. of Urology, Copenhagen, Denmark, ²Stanford University Medical Center, Dept. of Urology, Stanford, United States of America, ³University of Copenhagen, Dept. of Biostatistics, Copenhagen, Denmark, ⁴Rigshospitalet, Dept. of Clinical Physiology, Nuclear Medicine & PET and Cluster For Molecular Imaging, Copenhagen, Denmark

1077

Obesity was associated with improved metastases-free survival after surgery in 13,667 prostate cancer patients

By: Tennstedt P.¹, Salomon G.¹, Tilki D.¹, Budäus L.¹, Pompe R.¹, Leyh-Bannurah S-R.², Haese A.¹, Heinzer H.¹, Huland H.¹, Graefen M.¹, Schiffmann J.³

Institutes: ¹University Medical Center Eppendorf, Martini-Klinik, Hamburg, Germany, ²University Medical Center Eppendorf, Department of Urology, Hamburg, Germany, ³Academic Hospital Braunschweig, Department of Urology, Braunschweig, Germany

1078

Functional outcomes and complications of a multicentre series of open versus robot-assisted salvage radical prostatectomy

By: Gontero P.¹, Marra G.¹, Alessio P.¹, Oderda M.¹, Palazzetti A.¹, Pisano F.¹, Battaglia A.¹, Munegato S.¹, Frea B.¹, Munoz F.², Filippini C.³, Linares E.⁴, Sanchez-Salas R.⁴, Goonewardene S.⁵, Dasgupta P.⁵, Cahill D.⁵, Challacombe B.⁵, Popert R.⁵, Gillatt D.⁶, Persad R.⁶, Palou J.⁷, Joniau S.⁸, Smelzo S.⁹, Piechaud T.⁹, De La Taille A.¹⁰, Roupret M.¹¹, Albisinni S.¹², Van Velthoven R.¹², Morlacco A.¹³, Vidit S.¹³, Gandaglia G.¹⁴, Mottrie A.¹⁴, Smith J.¹⁵, Fiscus G.¹⁵, Van Der Poel H.¹⁶, Tilki D.¹⁷, Karnes R.J.¹³

Institutes: ¹San Giovanni Battista Hospital, Dept. of Urology, Turin, Italy, ²Pasini Hospital, Dept. of Radiotherapy, Aosta, Italy, ³San Giovanni Battista Hospital, Dept. of Statistics, Turin, Italy, ⁴Institut Mutualiste Montsouris, Dept. of Urology, Paris, France, ⁵Guy’s Hospital, Dept. of Urology, London, United Kingdom, ⁶North Bristol NHS Foundation Trust, Dept. of Urology, Bristol, United Kingdom, ⁷Fundaciò Puigvert, Dept. of Urology, Barcelona, Spain, ⁸Leuven University Hospitals, Dept. of Urology, Leuven, Belgium, ⁹Clinique Saint Augustin, Dept. of Urology, Bordeaux, France, ¹⁰CHU Mondor, Dept. of Urology, Créteil, France, ¹¹Pitié Salpétrière Hospital- University Paris 6, Dept. of Urology, Paris, France, ¹²Institut Jules Bordet, Université Libre De Bruxelles,, Dept. of Urology, Brussels, Belgium, ¹³Mayo Clinic, Dept. of Urology, Rochester, United States of America, ¹⁴OLV Hospital, Dept. of Urology, Aalst, Belgium, ¹⁵Vanderbilt University, Medical Center North, Dept. of Urology, Nashville, United States of America, ¹⁶Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands, ¹⁷Martini Klinik, Dept. of Urology, Hamburg, Germany

1079

Impact of type of radical prostatectomy on outcomes reported by men with prostate cancer 18 months post-diagnosis: Results from the English National Prostate Cancer Audit (NPCA)

By: Nossiter J.¹, Sujenthiran A.², Charman S.³, Cathcart P.⁴, Aggarwal A.³, Payne H.⁵, Clarke N.⁶, Van Der Meulen J.⁷

Institutes: ¹Royal College Of Surgeons Of England, Dept.t of Clinical Effectiveness, London, United Kingdom, ²Royal College Of Surgeons Of England, Dept. of Clinical Effectiveness, London, United Kingdom, ³London School of Hygiene and Tropical Medicine, Dept. of Health Services Research & Policy, London, United Kingdom, ⁴Guy’s and St Thomas’ Hospital, NHS Foundation Trust, London, United Kingdom, ⁵University College London Hospitals, London NHS Foundation Trust, London, United Kingdom, ⁶The Christie and Salford Royal NHS Foundation Trusts, NHS Foundation Trusts, London, United Kingdom, ⁷ London School of Hygiene and Tropical Medicine, Dept. of Health Services Research & Policy, London, United Kingdom

Abstract

1081

Randomized study evaluating postoperative outcomes in patients with complex anastomosis during da Vinci prostatectomy

By: Pushkar D., Kolontarev K., Govorov A., Rasner P.

Institutes: Moscow State Medico Stomatological University, Hospital 50, Dept. of Urology, Moscow, Russia

1082

Surgical expertise is the major determinant of decreased complication rates in contemporary patients treated with robot-assisted radical prostatectomy

By: Dell’Oglio P.¹, Stabile A.¹, Zaffuto E.¹, Gandaglia G.¹, Fossati N.¹, Bandini M.¹, Moschini M.¹, Fallara G.¹, Dehò F.¹, Guazzoni G.², Gallina A.¹, Suardi N.¹, Gaboardi F.¹, Montorsi F.¹, Briganti A.¹

Institutes: ¹Vita-Salute University San Raffaele, Dept. of Urology, Milan, Italy, ²Humanitas Clinical and Research Center, Dept. of Urology, Milan, Italy

1083

Characterization of the “one-pad patient” at long-term follow-up after radical prostatectomy

By: Löppenberg B., Müller G., Bach P., Von Bodman C., Brock M., Roghmann F., Noldus J., Palisaar J.

Institutes: Ruhr-University Bochum, Marien Hospital Herne, Dept. of Urology, Herne, Germany

Abstract